NovoCure's total assets for Q3 2024 were $1.22B, an increase of 0.81% from the previous quarter. NVCR total liabilities were $861.21M for the fiscal quarter, a 1.27% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.